With a variety of new (and expensive) therapies in the pipeline for 2023, it is understandable that the industry is feeling anxiety over the rise of high-cost drugs. However, there is not one-size-fits all solution. Industry stakeholders must consider and respond differently to each drug type.

In this episode, host Rachel (Rae) Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to discuss how industry stakeholders are thinking about different high-cost drugs and how they can prepare for the future.

Links:

Learn more about Advisory Board On-Demand Courses

Last week we discussed the current state of employer-sponsored insurance and the affordability challenges that the employers are facing. This week, we'll be taking a look at one possible solution for employers: value-based care.

In this episode, host Rachel (Rae) Woods invites Advisory Board value-based care experts Daniel Kuzmanovich and Sophia Hurr to discuss the opportunity that value-based care presents for employers to reduce the costs of care while increasing the quality of care their employees receive. Throughout the conversation, they explore what kinds of employers are best positioned to pursue value-based care, and the different paths to get there.

Links:

Learn more about Advisory Board Events at advisory.com/resources/events

While always facing a dynamic landscape, one of the biggest issues today in the employer-sponsored insurance market is affordability. As healthcare costs continue to rise, employers are getting increasingly nervous about their ability to pay for employees’ health insurance, especially in a time of heightened worker shortages.

In this episode, guest host and Advisory Board Vice President and spokesperson Aaron Mauck discusses employer market affordability with Advisory Board health plan experts Sally Kim and Max Hakanson. Throughout the conversation, they explore the context of the problem, root causes, and what the future may look like for employer-sponsored insurance.

Links:

Learn more about Advisory Board On-Demand Courses

Episode 138 was originally released on October 25, 2022.

This week, we're bringing you an encore of our episode with Tom Lawry, the former national director for AI at Microsoft about building ethical AI systems. Not only did this episode recently receive accolades from this year's Communicator Awards – including best healthcare and pharma episode and best business episode – but this conversation is just as, if not more relevant as it was when we recorded it in the Fall of 2022.

While we have a lot to learn about these new technologies, it is clear that AI is top of mind for digital health leaders in 2023. However, revelations about equity issues and bias in artificial intelligence are increasingly giving cause for concern. In this encore of Episode 138, Rachel (Rae) Woods invites Microsoft's former Director for Artificial Intelligence Tom Lawry to discuss how bias creeps into AI and how leaders can respond to make intelligent systems more equitable.

Tom Lawry is the author of Hacking Healthcare, which details lessons learned from AI's role during global pandemic and how to apply this knowledge to healthcare’s other big challenges – including inequity.

Links:

Learn more about Advisory Board Events at advisory.com/resources/events

Hospitals and health systems across the globe are looking towards environmental sustainability. However, in a tumultuous economic environment, it can be challenging to balance sustainability efforts with bottom-line necessities while operating under tight margins.

In this episode, guest host and Advisory Board's environmental sustainability expert Miles Cottier invites Bob Biggio, Senior Vice President of Facilities & Support Services at Boston Medical Center, to discuss long-term green financing strategies. Throughout the discussion, they explore Boston Medical Center's medical campus redesign, issuing of "Green Bonds," and their efforts balance sustainability with efficiency and cost-savings.

Links:

Learn more about Advisory Board Events at advisory.com/resources/events

Vertical integration and consolidation are significantly altering the healthcare landscape. From health plans to retailers to incumbent health systems, consolidation is reshaping conventional norms in the industry.

In this episode, host Rachel (Rae) Woods speaks with Advisory Board experts Paul Trigonoplos and Eliza Dailey about the reasons for and reactions to the recent explosion in consolidation across the industry. Throughout the discussion, they explore how different stakeholders are responding, and where the future is heading for diversification and integration.

Links:

Learn more about the Advisory Board Fellowship (advisory.com/fellowship)

Recent research shows that the workforce shortage – particularly among registered nurses – is the top issue for healthcare CEOs. While a nursing shortage is challenging for nursing departments, there are a host of systemwide problems that will impact quality and safety of care alongside an organization's ability to grow.

In this episode, host Rachel (Rae) Woods speaks with Advisory Board's Chief Nursing Officer, Carol Boston, and two leaders from University Hospitals – Chief Quality & Clinical Transformation Officer, Peter Pronovost, and Chief Nursing Executive, Michelle Hereford – about recent data and their experiences navigating the complexity of the workforce shortage. They explore how the shortage is impacting health organizations at large, why organizations can't seem to find a solution, and how addressing tactical issues alone will not solve the crisis.

Links:

In 2018, Wellmont Health System and Mountain States Health Alliance, who both served regions of Northeast Tennessee and Southwest Virginia, merged to create one organization – Ballad Health. The merger was seen by leadership as essential but led to a host of difficult decisions and even public backlash. So, how did leaders work to navigate such a complex environment?

In part two of Radio Advisory's Leadership series, host Rachel Woods invites Lisa Carter, the CEO of Ballad Health's Southern Market, to discuss her experience navigating complex challenges and a contentious response to the merger of two legacy health systems in Northern Tennessee.

Links:

Learn more about Advisory Board Sponsorship opportunities at advisory.com/sponsorship

The past few years have been filled with complexity. Through the COVID-19 pandemic, financial pressures, workforce challenges and more, it has become increasingly difficulty to make sense of such an uncertain environment. One thing is for sure: this complexity isn't going away, so how can leaders work to navigate this ambiguity?

In part one of Radio Advisory's leadership series, host Rachel Woods invites Advisory Board's expert on executive development, Matt Cornner to discuss leading in times of complexity. We'll also hear from Advisory Board's CEO, Adele Scielzo and two UnitedHealth Group leaders – chief medical officer Dr. Margaret-Mary Wilson, and chief sustainability officer Patricia Lewis – about leadership challenges they've faced, finding purpose, and building momentum.

Links:

Learn more about the Advisory Board Fellowship (advisory.com/fellowship)

Advisory Board is a subsidiary of UnitedHealth Group. All Advisory Board research, expert perspectives, and recommendations remain independent.

Demand – and concern – is growing for the newest generation of weight loss drugs. Approved by the FDA to treat type 2 diabetes, drugs like Ozempic and Wegovy have set off a media frenzy as celebrities and the wealthy touted their weight loss benefits. Leaders have a lot of questions about protocol, supply, and coverage of these drugs, and the consequences of patients using them for their unintended purpose. In this episode, host Rachel (Rae) Woods walks through these questions with experts Kara Marlatt, Gaby Marmolejos, and Chloe Bakst and discuss the potential future of weight management in US healthcare.

Links:

Learn more about Advisory Board Sponsorship opportunities at advisory.com/sponsorship